Cargando…
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
BACKGROUND: Identifying the subset of patients with clinically localized prostate cancer (PCa) at the highest risk of recurrence remains challenging, and better prognostic markers are needed. Gleason score is the best predictor of PCa aggressiveness and prognosis. In the present study, we generated...
Autores principales: | Geybels, Milan S., Wright, Jonathan L., Bibikova, Marina, Klotzle, Brandy, Fan, Jian-Bing, Zhao, Shanshan, Feng, Ziding, Ostrander, Elaine A., Lin, Daniel W., Nelson, Peter S., Stanford, Janet L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024414/ https://www.ncbi.nlm.nih.gov/pubmed/27651837 http://dx.doi.org/10.1186/s13148-016-0260-z |
Ejemplares similares
-
Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort
por: Jhun, Min A., et al.
Publicado: (2017) -
PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles
por: Geybels, Milan S., et al.
Publicado: (2017) -
Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors
por: Geybels, Milan S., et al.
Publicado: (2015) -
A five‐CpG DNA methylation score to predict metastatic‐lethal outcomes in men treated with radical prostatectomy for localized prostate cancer
por: Zhao, Shanshan, et al.
Publicado: (2018) -
Gene expression panel predicts metastatic‐lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer
por: Rubicz, Rohina, et al.
Publicado: (2016)